Connect with us

Duniya

Masana kimiyya sun ba da shawarar sabuwar dabara don magance cututtukan hanji mai kumburi –

Published

on

  Masu bincike na kasar Sin da na kasashen waje sun tabbatar da wani sabon magani mai inganci wajen magance matsakaita da matsananciyar ciwon ulcer cutar hanji mai kumburi IBD wanda ya kawo sabon zabin magani A matsayin rukuni na cututtukan kumburi na yau da kullun IBDs galibi sun ha a da ulcerative colitis da cutar Crohn Suna da saurin kai hare hare akai akai tare da pathogenesis ba a fahimta sosai ba tukuna An yi imanin Interleukin 6 IL 6 shine babban mai shiga tsakani na pathogenesis bisa ga masu binciken Magungunan da ake da su sun nuna mummunan tasirin warkewa akan IBDs don haka dabarun jiyya shine don sarrafa alamun bayyanar cututtuka da hana sake dawowarsu ta hanyar hana amsawar rigakafi Sabbin magungunan cikin gida olamkicept furotin ne mai narkewa kuma yana iya za in hana siginar IL 6 A lokacin gwajin gwaji na 2 na asibiti ungiyar ha in gwiwa karkashin jagorancin masu bincike daga Asibitin Farko na Jami ar Sun Yat sen FAH tare da ha in gwiwar takwarorinsu daga asibitocin 22 da cibiyoyin bincike a Gabashin Asiya sun gudanar da bazuwar makafi biyu da nazarin placebo sarrafawa Zhang Shenghong wani mamba daga hukumar ta FAH ya ce adadin manya manya marasa lafiya 91 da ke fama da ciwon ulcer wadanda ke da matsakaicin shekaru 41 sun shiga cikin binciken tun daga watan Fabrairun 2018 An raba su ba tare da izini ba zuwa rukuni uku na kusan daidaitattun lambobi kuma sun sami jiko na olamkicept ta jijiya tare da kashi 600 milligrams ko 300 milligrams ko placebo bi da bi na tsawon makonni 12 Sakamakon ya nuna cewa olamkicept tare da kashi na 600 milligrams ya nuna tasirin warkewa ga marasa lafiya masu matsakaici da matsananciyar ulcerative colitis ta hanyar inganta alamun asibiti da alamun ilimin halitta Chen Minhu shugaban tawagar daga FAH ya ce maganin yana da lafiya kuma yana da kyau kuma yana iya rage rikice rikice da mace mace a cikin marasa lafiya da IBDs Ya ce zai shiga gwaji na asibiti kashi 3 a wannan shekara inda ya kara da cewa an buga sakamakon binciken da ya gabata a cikin The Journal of the American Medical Association JAMA Xinhua NAN Credit https dailynigerian com scientists propose strategy
Masana kimiyya sun ba da shawarar sabuwar dabara don magance cututtukan hanji mai kumburi –

Masu bincike na kasar Sin da na kasashen waje sun tabbatar da wani sabon magani mai inganci wajen magance matsakaita da matsananciyar ciwon ulcer, cutar hanji mai kumburi (IBD), wanda ya kawo sabon zabin magani.

blogger outreach editorial pricing today's nigerian newspapers headlines

A matsayin rukuni na cututtukan kumburi na yau da kullun, IBDs galibi sun haɗa da ulcerative colitis da cutar Crohn.

today's nigerian newspapers headlines

Suna da saurin kai hare-hare akai-akai, tare da pathogenesis ba a fahimta sosai ba tukuna. An yi imanin Interleukin-6 (IL-6) shine babban mai shiga tsakani na pathogenesis bisa ga masu binciken.

today's nigerian newspapers headlines

Magungunan da ake da su sun nuna mummunan tasirin warkewa akan IBDs, don haka dabarun jiyya shine don sarrafa alamun bayyanar cututtuka da hana sake dawowarsu ta hanyar hana amsawar rigakafi.

Sabbin magungunan cikin gida, olamkicept, furotin ne mai narkewa kuma yana iya zaɓin hana siginar IL-6.

A lokacin gwajin gwaji na 2 na asibiti, ƙungiyar haɗin gwiwa karkashin jagorancin masu bincike daga Asibitin Farko na Jami’ar Sun Yat-sen, FAH, tare da haɗin gwiwar takwarorinsu daga asibitocin 22 da cibiyoyin bincike a Gabashin Asiya, sun gudanar da bazuwar, makafi biyu, da nazarin placebo-sarrafawa.

Zhang Shenghong, wani mamba daga hukumar ta FAH, ya ce adadin manya manya marasa lafiya 91 da ke fama da ciwon ulcer, wadanda ke da matsakaicin shekaru 41, sun shiga cikin binciken, tun daga watan Fabrairun 2018.

An raba su ba tare da izini ba zuwa rukuni uku na kusan daidaitattun lambobi kuma sun sami jiko na olamkicept ta jijiya tare da kashi 600 milligrams ko 300 milligrams, ko placebo, bi da bi, na tsawon makonni 12.

Sakamakon ya nuna cewa olamkicept tare da kashi na 600 milligrams ya nuna tasirin warkewa ga marasa lafiya masu matsakaici da matsananciyar ulcerative colitis ta hanyar inganta alamun asibiti da alamun ilimin halitta.

Chen Minhu, shugaban tawagar daga FAH ya ce maganin yana da lafiya kuma yana da kyau kuma yana iya rage rikice-rikice da mace-mace a cikin marasa lafiya da IBDs.

Ya ce zai shiga gwaji na asibiti kashi 3 a wannan shekara inda ya kara da cewa an buga sakamakon binciken da ya gabata a cikin The Journal of the American Medical Association, JAMA.

Xinhua/NAN

Credit: https://dailynigerian.com/scientists-propose-strategy/

rariya labaran hausa free shortner downloader for instagram

Mun fassara wannan labari daga Turanci zuwa wannan harshe. Ba za mu iya ba da tabbacin cewa ya yi daidai ba. Da fatan za a kula.